Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 19/20 | 0.88 |
| ▸ | LITAF | Q99732 | 19/20 | 0.88 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.88 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31355049 | 1.00 | TNF (0.88) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL24164518 | 1.00 | TNF (0.88) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL29514464 | 1.00 | TNF (0.88) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL26145969 | 1.00 | TNF (0.88) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL29381799 | 1.00 | TNF (0.88) | TNFLITAFPDE4BPDE4D | |
| Hydrochloric Acid SCHEMBL29384439 | 0.99 | TNF (0.86) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL2016365 | 0.93 | TNF (1.00) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL2016363 | 0.93 | TNF (1.00) | TNFLITAFPDE4BPDE4D | |
| SCHEMBL2018501 | 0.93 | TNF (1.00) | TNFLITAFPDE4BPDE4D | |
| Hydrochloric Acid SCHEMBL2016839 | 0.93 | TNF (0.98) | TNFLITAFPDE4BPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000865-A1 | COMPOUND FOR REDUCING URIC ACID LEVELS | NEWSOARA BIOPHARMA CO., LTD. (CN) | 2025-01-02 | — | — | US | disclosed |
| WO-2023083296-A1 | COMPOUND FOR REDUCING URIC ACID LEVELS | 恒翼生物医药(上海)股份有限公司 | 2023-05-19 | — | — | WO | disclosed |
| CN-113768937-B | Compounds for reducing uric acid levels | 恒翼生物医药科技(上海)有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-113768937-A | Compounds for reducing uric acid levels | 恒翼生物医药科技(上海)有限公司 | 2021-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000865-A1 | COMPOUND FOR REDUCING URIC ACID LEVELS | PDE4A, PDE4B, PDE12 | TNF 526/4885LITAF 1814/4885PDE4B 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.